Lower Limb Amputations: Across four empagliflozin outcome trials, lower limb amputation event rates were 4.3 and 5.0 events per 1,000 patient-years in the placebo group and the empagliflozin 10 mg or 25 mg dose group, respectively, with a HR of 1.05 (95% CI) (0.81, 1.36)
doi: 10.3233/JAD-191304 40 LinC
Boosts Skin Detoxification Think of glutathione as an internal cleanser
ACS Nano 18, 62296242
In vitro data suggest that the primary route of metabolism of empagliflozin in humans is glucuronidation by the uridine 5-diphospho-glucuronosyltransferases UGT1A3, UGT1A8, UGT1A9, and UGT2B7
Huateng Pharma, founded in 2013, is a one-stop contract development and manufacturing organization (CDMO) to supply researchers and companies with PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents